Washington, DC, April 20, 2017 – Friends of Cancer Research (Friends) Chairperson & Founder, Ellen V. Sigal, will receive the Face of Hope award at LUNGevity’s Celebration of Hope event tomorrow evening. The Face of Hope award is presented to an individual who recognizes the needs of those living with lung cancer and is actively…
Today, at 10am ET, Dr. Scott Gottlieb, the President’s nominee for FDA Commissioner, will appear before the Senate Health, Education, Labor and Pensions (HELP) Committee for his confirmation hearing. We will be live-tweeting the hearing: Follow us on Twitter for the latest Senate HELP will also be broadcasting the hearing via webcast The Advocacy…
Washington, DC, March 27, 2017 – Today, Friends of Cancer Research (Friends) launched a new online learning community, ProgressForPatients.org. The site is home to two new programs Friends has been developing over the course of the last year, Friends’ Advocacy Education and Advocacy Alliance. “We set out to create an online community, a place where…
The first House PDUFA reauthorization hearing is scheduled to take place at 10:15 am ET today, Wednesday, March 22, 2017, in the U.S. House of Representatives. Friends of Cancer Research President & CEO Dr. Jeff Allen will testify as to the importance of user fees during today’s hearing, along with FDA’s Dr. Janet Woodcock and…
Washington, D.C., March 21, 2017—The National Organization for Rare Disorders (NORD) and Friends of Cancer Research, two leading organizations that collectively represent millions of Americans with cancer and rare diseases, issued the following statement in advance of this week’s congressional hearings on the reauthorization of FDA user fees: “We wish to congratulate the Senate Committee…
President Nominates Dr. Scott Gottlieb for FDA Commissioner Friends Urges Swift Confirmation Washington, DC, March 10, 2017 – Friends of Cancer Research (Friends) strongly supports President Trump’s nomination of Dr. Scott Gottlieb to serve as the next FDA Commissioner and urges Congress to work quickly to confirm his appointment. “We deeply respect Dr. Gottlieb and have…
Historic Innovation Bill to be Signed Into Law: House, Senate & White House, Unified, Pass Major Bipartisan Action in Final Days of the 114th Congress & Obama Administration Bill Secures Future of Vice President’s Cancer Moonshot Washington, DC – December 7, 2016 – Friends of Cancer Research (Friends) applauds Congress and the White House for…
Collaborative Program Will Provide Support for Quality-of-Life Research for Cancer Survivors Vice President Joe Biden released today a final report on the Cancer Moonshot Task Force, naming the Health and Environmental Sciences Institute’s (HESI’s) THRIVE Network as a participant in the Moonshot’s efforts to further advance the task force’s goals. The Moonshot program is focused…
October 5, 2016 – Washington, DC – Today, Friends of Cancer Research (Friends) is co-hosting a summit with the Parker Institute for Cancer Immunotherapy titled, Optimizing the Use of Immunotherapy. The summit will bring together more than 50 leaders who are pioneering the field of immuno-oncology from across the country. The goal is to identify…
Washington, DC – October 4, 2016 – Friends of Cancer Research (Friends) announced today that Ryan Hohman, JD, who previously served as Managing Director, has been named Vice President – Public Affairs. This promotion is part of a larger organizational growth strategy that was initiated with the August announcement of Jeff Allen, PhD, becoming President…
